1552 studies found for:    alzheimer disease
Show Display Options
Rank Status Study
21 Active, not recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease
Intervention:
22 Completed
Has Results
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol;   Drug: Memantine;   Drug: Placebo
23 Completed
Has Results
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Interferon beta-1a;   Drug: Placebo
24 Unknown  Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
25 Completed Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases;   Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
26 Completed
Has Results
Minocycline in Patients With Alzheimer's Disease
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention: Drug: Minocycline
27 Completed Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
28 Recruiting Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Condition: Alzheimer's Disease
Interventions: Drug: Solanezumab;   Drug: Placebo
29 Completed Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Memory Loss;   Cognitive Impairment
Intervention: Drug: ladostigil hemitartrate
30 Completed Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
31 Completed Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 0.1 mg/kg;   Biological: PF-04360365 0.5 mg/kg;   Biological: PF-04360365 1 mg/kg;   Drug: Placebo;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 8.5 mg/kg
32 Terminated
Has Results
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
33 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
34 Completed
Has Results
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine 5 and 10 cm^2 patch
35 Completed Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 8.5 mg/kg;   Drug: Placebo
36 Completed
Has Results
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
Condition: Alzheimer Disease
Interventions: Drug: Rivastigmine 5 cm^2;   Drug: Rivastigmine 10 cm^2;   Drug: Rivastigmine 15 cm^2;   Drug: Placebo to 15 cm^2 patch;   Drug: Placebo to 10 cm^2 patch
37 Completed
Has Results
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
38 Completed
Has Results
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Dementia of the Alzheimer's Type
Interventions: Drug: memantine ER;   Drug: Placebo
39 Completed Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
Condition: Alzheimer's Disease
Intervention:
40 Not yet recruiting Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Condition: Alzheimer Disease
Interventions: Drug: Cerebrolysin;   Drug: Donepezil

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years